nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.276	0.57	CbGbCtD
Tiotropium—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0605	0.125	CbGbCtD
Tiotropium—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0563	0.116	CbGbCtD
Tiotropium—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0258	0.0534	CbGbCtD
Tiotropium—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0254	0.0525	CbGbCtD
Tiotropium—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0237	0.0489	CbGbCtD
Tiotropium—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0162	0.0334	CbGbCtD
Tiotropium—Aclidinium—BCHE—peripheral nervous system neoplasm	0.00969	1	CrCbGaD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000721	0.00142	CcSEcCtD
Tiotropium—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000721	0.00142	CcSEcCtD
Tiotropium—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000715	0.00141	CcSEcCtD
Tiotropium—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	0.000714	0.00141	CcSEcCtD
Tiotropium—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.0014	CcSEcCtD
Tiotropium—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00071	0.0014	CcSEcCtD
Tiotropium—Myalgia—Vincristine—peripheral nervous system neoplasm	0.0007	0.00138	CcSEcCtD
Tiotropium—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.00138	CcSEcCtD
Tiotropium—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000694	0.00137	CcSEcCtD
Tiotropium—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000692	0.00137	CcSEcCtD
Tiotropium—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000691	0.00136	CcSEcCtD
Tiotropium—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00069	0.00136	CcSEcCtD
Tiotropium—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000685	0.00135	CcSEcCtD
Tiotropium—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000685	0.00135	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000684	0.00135	CcSEcCtD
Tiotropium—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000683	0.00135	CcSEcCtD
Tiotropium—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000682	0.00135	CcSEcCtD
Tiotropium—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00068	0.00134	CcSEcCtD
Tiotropium—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000677	0.00134	CcSEcCtD
Tiotropium—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000677	0.00134	CcSEcCtD
Tiotropium—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00134	CcSEcCtD
Tiotropium—Oedema—Vincristine—peripheral nervous system neoplasm	0.000671	0.00133	CcSEcCtD
Tiotropium—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000668	0.00132	CcSEcCtD
Tiotropium—Infection—Vincristine—peripheral nervous system neoplasm	0.000667	0.00132	CcSEcCtD
Tiotropium—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000658	0.0013	CcSEcCtD
Tiotropium—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000655	0.00129	CcSEcCtD
Tiotropium—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00065	0.00128	CcSEcCtD
Tiotropium—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00065	0.00128	CcSEcCtD
Tiotropium—Back pain—Etoposide—peripheral nervous system neoplasm	0.000644	0.00127	CcSEcCtD
Tiotropium—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000642	0.00127	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000634	0.00125	CcSEcCtD
Tiotropium—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.00124	CcSEcCtD
Tiotropium—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00123	CcSEcCtD
Tiotropium—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00122	CcSEcCtD
Tiotropium—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000619	0.00122	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000615	0.00121	CcSEcCtD
Tiotropium—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000614	0.00121	CcSEcCtD
Tiotropium—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.00121	CcSEcCtD
Tiotropium—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000613	0.00121	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000611	0.00121	CcSEcCtD
Tiotropium—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000608	0.0012	CcSEcCtD
Tiotropium—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000608	0.0012	CcSEcCtD
Tiotropium—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000607	0.0012	CcSEcCtD
Tiotropium—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000603	0.00119	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.00119	CcSEcCtD
Tiotropium—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000595	0.00118	CcSEcCtD
Tiotropium—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000594	0.00117	CcSEcCtD
Tiotropium—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000593	0.00117	CcSEcCtD
Tiotropium—Infection—Cisplatin—peripheral nervous system neoplasm	0.000589	0.00116	CcSEcCtD
Tiotropium—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000589	0.00116	CcSEcCtD
Tiotropium—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000585	0.00116	CcSEcCtD
Tiotropium—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000584	0.00115	CcSEcCtD
Tiotropium—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000584	0.00115	CcSEcCtD
Tiotropium—Rash—Topotecan—peripheral nervous system neoplasm	0.000584	0.00115	CcSEcCtD
Tiotropium—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000583	0.00115	CcSEcCtD
Tiotropium—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000582	0.00115	CcSEcCtD
Tiotropium—Cough—Etoposide—peripheral nervous system neoplasm	0.000581	0.00115	CcSEcCtD
Tiotropium—Headache—Topotecan—peripheral nervous system neoplasm	0.00058	0.00115	CcSEcCtD
Tiotropium—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Tiotropium—Rash—Tretinoin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Tiotropium—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Tiotropium—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Tiotropium—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Tiotropium—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000577	0.00114	CcSEcCtD
Tiotropium—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000577	0.00114	CcSEcCtD
Tiotropium—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000576	0.00114	CcSEcCtD
Tiotropium—Headache—Tretinoin—peripheral nervous system neoplasm	0.000576	0.00114	CcSEcCtD
Tiotropium—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000576	0.00114	CcSEcCtD
Tiotropium—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000575	0.00114	CcSEcCtD
Tiotropium—Constipation—Vincristine—peripheral nervous system neoplasm	0.000574	0.00113	CcSEcCtD
Tiotropium—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00113	CcSEcCtD
Tiotropium—Rash—Melphalan—peripheral nervous system neoplasm	0.000572	0.00113	CcSEcCtD
Tiotropium—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000571	0.00113	CcSEcCtD
Tiotropium—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000569	0.00112	CcSEcCtD
Tiotropium—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000568	0.00112	CcSEcCtD
Tiotropium—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000567	0.00112	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000563	0.00111	CcSEcCtD
Tiotropium—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000553	0.00109	CcSEcCtD
Tiotropium—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.00109	CcSEcCtD
Tiotropium—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00109	CcSEcCtD
Tiotropium—Nausea—Topotecan—peripheral nervous system neoplasm	0.00055	0.00109	CcSEcCtD
Tiotropium—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000549	0.00108	CcSEcCtD
Tiotropium—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000546	0.00108	CcSEcCtD
Tiotropium—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000546	0.00108	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000541	0.00107	CcSEcCtD
Tiotropium—Infection—Etoposide—peripheral nervous system neoplasm	0.00054	0.00107	CcSEcCtD
Tiotropium—Nausea—Melphalan—peripheral nervous system neoplasm	0.000539	0.00106	CcSEcCtD
Tiotropium—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000536	0.00106	CcSEcCtD
Tiotropium—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.00105	CcSEcCtD
Tiotropium—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000533	0.00105	CcSEcCtD
Tiotropium—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000531	0.00105	CcSEcCtD
Tiotropium—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00053	0.00105	CcSEcCtD
Tiotropium—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000528	0.00104	CcSEcCtD
Tiotropium—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.00104	CcSEcCtD
Tiotropium—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000522	0.00103	CcSEcCtD
Tiotropium—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000513	0.00101	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000512	0.00101	CcSEcCtD
Tiotropium—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000989	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000983	CcSEcCtD
Tiotropium—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000979	CcSEcCtD
Tiotropium—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000494	0.000976	CcSEcCtD
Tiotropium—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000973	CcSEcCtD
Tiotropium—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000488	0.000964	CcSEcCtD
Tiotropium—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000954	CcSEcCtD
Tiotropium—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000954	CcSEcCtD
Tiotropium—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000478	0.000943	CcSEcCtD
Tiotropium—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000474	0.000935	CcSEcCtD
Tiotropium—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00047	0.000927	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000469	0.000927	CcSEcCtD
Tiotropium—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000466	0.00092	CcSEcCtD
Tiotropium—Constipation—Etoposide—peripheral nervous system neoplasm	0.000465	0.000918	CcSEcCtD
Tiotropium—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000917	CcSEcCtD
Tiotropium—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000915	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.00091	CcSEcCtD
Tiotropium—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00046	0.000909	CcSEcCtD
Tiotropium—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000451	0.00089	CcSEcCtD
Tiotropium—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000885	CcSEcCtD
Tiotropium—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000883	CcSEcCtD
Tiotropium—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.000881	CcSEcCtD
Tiotropium—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000444	0.000878	CcSEcCtD
Tiotropium—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000444	0.000876	CcSEcCtD
Tiotropium—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.000874	CcSEcCtD
Tiotropium—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000867	CcSEcCtD
Tiotropium—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000866	CcSEcCtD
Tiotropium—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000437	0.000863	CcSEcCtD
Tiotropium—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000436	0.000861	CcSEcCtD
Tiotropium—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000858	CcSEcCtD
Tiotropium—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000432	0.000853	CcSEcCtD
Tiotropium—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000851	CcSEcCtD
Tiotropium—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00043	0.000849	CcSEcCtD
Tiotropium—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00043	0.000849	CcSEcCtD
Tiotropium—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000849	CcSEcCtD
Tiotropium—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000427	0.000843	CcSEcCtD
Tiotropium—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000841	CcSEcCtD
Tiotropium—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000836	CcSEcCtD
Tiotropium—Rash—Vincristine—peripheral nervous system neoplasm	0.000423	0.000835	CcSEcCtD
Tiotropium—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000423	0.000835	CcSEcCtD
Tiotropium—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000834	CcSEcCtD
Tiotropium—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000832	CcSEcCtD
Tiotropium—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00083	CcSEcCtD
Tiotropium—Headache—Vincristine—peripheral nervous system neoplasm	0.00042	0.00083	CcSEcCtD
Tiotropium—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000823	CcSEcCtD
Tiotropium—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000819	CcSEcCtD
Tiotropium—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.000817	CcSEcCtD
Tiotropium—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000816	CcSEcCtD
Tiotropium—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000791	CcSEcCtD
Tiotropium—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0004	0.000791	CcSEcCtD
Tiotropium—Nausea—Vincristine—peripheral nervous system neoplasm	0.000399	0.000787	CcSEcCtD
Tiotropium—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000786	CcSEcCtD
Tiotropium—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000778	CcSEcCtD
Tiotropium—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000774	CcSEcCtD
Tiotropium—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000772	CcSEcCtD
Tiotropium—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00077	CcSEcCtD
Tiotropium—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000768	CcSEcCtD
Tiotropium—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000768	CcSEcCtD
Tiotropium—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000765	CcSEcCtD
Tiotropium—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000763	CcSEcCtD
Tiotropium—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000385	0.000759	CcSEcCtD
Tiotropium—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000757	CcSEcCtD
Tiotropium—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000755	CcSEcCtD
Tiotropium—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000377	0.000745	CcSEcCtD
Tiotropium—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000742	CcSEcCtD
Tiotropium—Rash—Cisplatin—peripheral nervous system neoplasm	0.000374	0.000739	CcSEcCtD
Tiotropium—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000374	0.000738	CcSEcCtD
Tiotropium—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000737	CcSEcCtD
Tiotropium—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000732	CcSEcCtD
Tiotropium—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000713	CcSEcCtD
Tiotropium—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000711	CcSEcCtD
Tiotropium—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000359	0.00071	CcSEcCtD
Tiotropium—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000708	CcSEcCtD
Tiotropium—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000706	CcSEcCtD
Tiotropium—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.0007	CcSEcCtD
Tiotropium—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000352	0.000696	CcSEcCtD
Tiotropium—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000695	CcSEcCtD
Tiotropium—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000687	CcSEcCtD
Tiotropium—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000346	0.000682	CcSEcCtD
Tiotropium—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000682	CcSEcCtD
Tiotropium—Rash—Etoposide—peripheral nervous system neoplasm	0.000343	0.000677	CcSEcCtD
Tiotropium—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000342	0.000676	CcSEcCtD
Tiotropium—Headache—Etoposide—peripheral nervous system neoplasm	0.000341	0.000672	CcSEcCtD
Tiotropium—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000661	CcSEcCtD
Tiotropium—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00066	CcSEcCtD
Tiotropium—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000652	CcSEcCtD
Tiotropium—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000648	CcSEcCtD
Tiotropium—Cough—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000643	CcSEcCtD
Tiotropium—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000643	CcSEcCtD
Tiotropium—Nausea—Etoposide—peripheral nervous system neoplasm	0.000323	0.000638	CcSEcCtD
Tiotropium—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000637	CcSEcCtD
Tiotropium—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000628	CcSEcCtD
Tiotropium—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000628	CcSEcCtD
Tiotropium—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000628	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000623	CcSEcCtD
Tiotropium—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000614	CcSEcCtD
Tiotropium—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000612	CcSEcCtD
Tiotropium—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000603	CcSEcCtD
Tiotropium—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000602	CcSEcCtD
Tiotropium—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.0006	CcSEcCtD
Tiotropium—Infection—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000598	CcSEcCtD
Tiotropium—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000595	CcSEcCtD
Tiotropium—Shock—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000592	CcSEcCtD
Tiotropium—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000299	0.00059	CcSEcCtD
Tiotropium—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000589	CcSEcCtD
Tiotropium—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000587	CcSEcCtD
Tiotropium—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000584	CcSEcCtD
Tiotropium—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000581	CcSEcCtD
Tiotropium—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000581	CcSEcCtD
Tiotropium—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000581	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000577	CcSEcCtD
Tiotropium—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000568	CcSEcCtD
Tiotropium—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000557	CcSEcCtD
Tiotropium—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000553	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000548	CcSEcCtD
Tiotropium—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000548	CcSEcCtD
Tiotropium—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000546	CcSEcCtD
Tiotropium—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000544	CcSEcCtD
Tiotropium—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000543	CcSEcCtD
Tiotropium—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000541	CcSEcCtD
Tiotropium—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00054	CcSEcCtD
Tiotropium—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00053	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000519	CcSEcCtD
Tiotropium—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000515	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000507	CcSEcCtD
Tiotropium—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000504	CcSEcCtD
Tiotropium—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.0005	CcSEcCtD
Tiotropium—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000492	CcSEcCtD
Tiotropium—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00049	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000481	CcSEcCtD
Tiotropium—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000478	CcSEcCtD
Tiotropium—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000476	CcSEcCtD
Tiotropium—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000476	CcSEcCtD
Tiotropium—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000455	CcSEcCtD
Tiotropium—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000443	CcSEcCtD
Tiotropium—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000442	CcSEcCtD
Tiotropium—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00044	CcSEcCtD
Tiotropium—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000426	CcSEcCtD
Tiotropium—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00041	CcSEcCtD
Tiotropium—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000398	CcSEcCtD
Tiotropium—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000394	CcSEcCtD
Tiotropium—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000383	CcSEcCtD
Tiotropium—Rash—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000379	CcSEcCtD
Tiotropium—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000379	CcSEcCtD
Tiotropium—Headache—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000377	CcSEcCtD
Tiotropium—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000368	CcSEcCtD
Tiotropium—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000357	CcSEcCtD
Tiotropium—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000354	CcSEcCtD
Tiotropium—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000351	CcSEcCtD
Tiotropium—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000351	CcSEcCtD
Tiotropium—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000349	CcSEcCtD
Tiotropium—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000331	CcSEcCtD
